ghk-cu peptide hair growth clinical trial human trials studies copper ghk-cu hair growth clinical ghk cu clinical trials ghk-cu

The original 2015 Cell Metabolism study demonstrated that intraperitoneal MOTS-c injections (5 mg/kg) in mice fed a high-fat diet prevented obesity and insulin resistance, with effects on fat mass, fasting glucose, and insulin sensitivity that rivaled pharmaceutical intervention [1]

Results showed 55.8% reduction in wrinkle volume versus control serum and 31.6% reduction versus Matrixyl 3000

The compounds relatively small molecular structure and well-characterised analytical profile have contributed to its continued relevance within peptide research

Focus: Microbiome: Gut microbiome and infant health: Brain-gut-microbiota axis and host genetic factors